Eloxx Pharmaceuticals, Inc. ELOX
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +22.16%
- 1 year
- +22.16%
- Open
- 13.35
- Prev close
- 13.18
- Mkt cap
- 54.29M
- Vol
- 13.99K
- Avg vol
- 34.36K
- EPS
- 3.52
- P/E
- 3.82
- Div yield
- 0.00%
More statistics
- Low
- 12.99
- High
- 13.77
- Forward P/E
- -0.87
- Beta
- 2.61
- Short ratio
- 0.63
- Inst. own
- 43.97%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 23, 2024
- 50-d avg
- 6.06
- 200-d avg
- 5.01
- 1y target
- 55.00
5D chart
Signals (23)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:55 PM | 1 day ago |
| SMA: Bearish | Oct 30, 2:35 PM | 1 day ago |
| SMA: Bullish | Oct 29, 3:55 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:55 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:50 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:35 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:35 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 12:35 PM | 2 days ago |
| SMA: Bullish | Oct 29, 11:45 AM | 2 days ago |
| SMA: Bearish | Oct 29, 11:40 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:20 AM | 2 days ago |
| SMA: Bearish | Oct 28, 2:55 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:40 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:40 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:25 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:25 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:35 PM | 3 days ago |
| SMA: Bearish | Oct 28, 11:55 AM | 3 days ago |
| SMA: Bearish | Oct 28, 11:55 AM | 3 days ago |
| SMA: Bullish | Oct 27, 2:55 PM | 4 days ago |
| SMA: Bearish | Oct 27, 9:40 AM | 4 days ago |
| SMA: Bullish | Oct 26, 2:35 PM | 5 days ago |
Discussion (14)
Sign in to join the discussion
$ELOX positive news
Very positive news
?????????????? Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi
-- Royalty Pharma purchases a portion of royalties on Roche's Evrysdi for $1.0 billion upfront -- PTC Therapeutics has option to sell rest of royalty for up to $500 million; Royalty Pharma has option to buy half of rest of royalty for up to $250 million -- Transaction expected to enhance long-term Adjusted Cash Receipts growth (non-GAAP) -- Royalty Pharma to host conference call today, Thursday, October 19 at 9:00am EDT NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, Inc. to acquire additional royalties on Roche's Evrysdi for $1.0 billion upfront. The agreement includes options for PTC to sell up to all of its retained royalties on Evrysdi for up to $500 million or for Royalty Pharma to acquire half of such retained royalties for up to $250 million at a later date.
$ELOX …remember
$ELOX sell in may, go away. Low buys in september are the ones to remember. ;-)
Volume past 2 days has been much much greater than previous candles. Something is cooking.
$ELOX is it safe? IS IT SAFE?
$ELOX perhaps the secondary offering is almost complete. By reg, since the float is about 2.1m shares, only about 700k can be sold at this point(one third of the public float). Since the filing on May 15th, stock price $8.59 on the close, I calculate about 1.5m shares have traded to date. Oppenheimer might be done?
Excellent detailed presentation $ELOX
Going to spike soon. 18 EOM